Global Dialysis Concentrate Market Size (2024 - 2029)

The dialysis concentrate market is anticipated to experience growth driven by the increasing prevalence of kidney diseases such as end-stage renal disease and acute kidney injury, alongside a shortage of organ donors and risks associated with transplants. Technological advancements and initiatives by key players to introduce advanced products and services are also contributing to the market's expansion. Despite these positive trends, challenges such as complications in dialysis treatment and reimbursement policy issues in developing countries may hinder the market's growth.

Market Size of Global Dialysis Concentrate Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Dialysis Concentrate Market Size
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 5.73 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Dialysis Concentrate Market Analysis

The dialysis concentrate market is projected to grow with a CAGR of 5.73% during the forecast period (2022 - 2027).

Coronavirus disease 2019 (COVID-19) has impacted the care and results of dialysis patients worldwide. SARS-CoV-2 infection and mortality are more common among dialysis patients, and many have experienced psychological anguish and delayed or poor care. According to an article published by the National Center for Biotechnology Information in May 2022, titled "COVID-19 in Dialysis: Clinical Impact, Immune Response, Prevention and Treatment", 15% to 20% excess mortality rates have been observed in patients on dialysis in the United States, in early 2020. According to a research article published in July 2020 titled 'COVID-19 and the Kidneys: An Update' published in Frontiers in Medicine Journal, the study results indicate that patients with kidney disease could represent a risk factor in elderly patients for a more severe disease course. Furthermore, a research article published by Hemodialysis International Journal in November 2020, titled 'The Impact of COVID19 in Hemodialysis Patients: Experience in a Hospital Dialysis Unit', found that COVID-19 has shown a high incidence and mortality rate in hemodialysis patients. Thus, early preventive measures against COVID-19 could decrease the risk of spreading the disease in vulnerable patients.

The factors driving the growth of the dialysis concentrate market are the rising prevalence of kidney diseases such as end-stage renal disease (ESRD), acute kidney injury (AKI), shortage of organ donors, risks associated with transplants, technological advancements, and initiatives by the leading players to introduce advanced products and services. For instance, according to a research article published in September 2020, titled 'Association of Age With Risk of Kidney Failure in Adults With Stage IV Chronic Kidney Disease in Canada', the study results found that the incidence rate of stage IV chronic kidney disease increased with age. For those 75 years and older, the risk of death was much higher than that of kidney failure. The high burden of chronic kidney disease is expected to boost the market, increasing the demand for renal dialysis and further increasing the demand for dialysis concentrates in the coming years. According to the study published by PlosOne, in February 2022, titled "Prevalence of Chronic Kidney Disease Stages 3-5 in Low-and Middle-Income Countries in Asia: A Systematic Review and Metanalysis", it has been found that the prevalence of chronic kidney disease stages 3-5 in low-and middle-income countries was 11.2%. In addition, the prevalence rate for chronic kidney disease in east Asia was 12%, 8.6% in east Asia, 12% in south-east Asia, 13.1% in western Asia, and 13.5% in South Asia.

Moreover, the mortality rate associated with chronic kidney diseases is increasing. For instance, according to the Centers for Disease Control, 2021, it has been found that Mississippi had the highest mortality rate for chronic kidney disease, in 2020, in the United States.

However, the complications in dialysis treatment and reimbursement policy issues in growing countries could stifle the dialysis concentrate market's growth.

Dialysis Concentrate Industry Segmentation

As per the scope of the report, dialysis concentrate comprises purified water, glucose, and electrolytes and is used in hemodialysis, where the solution is created according to the requirement and aids in electrolyte regulation and the removal of metabolic waste products. The Global Dialysis Concentrate Market is segmented by Type (Acid Concentrates, Bicarbonate Concentrates, and Peritoneal Dialysis Fluid), Applications (Hemodialysis and Peritoneal Dialysis), Dialysis site (Hospital, Clinics & Dialysis Centers, and Home Dialysis) and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD million) for the above segments.

By Type
Acid Concentrates
Bicarbonate Concentrates
Peritoneal Dialysis Fluid
By Application
Hemodialysis
Peritoneal Dialysis
By Dialysis Site
Hospital
Clinics & Dialysis Centers
Home Dialysis
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Dialysis Concentrate Market Size Summary

The dialysis concentrate market is experiencing growth driven by the increasing prevalence of kidney diseases such as end-stage renal disease and acute kidney injury, alongside technological advancements and initiatives by leading industry players. The market is influenced by the rising demand for renal dialysis due to the shortage of organ donors and the risks associated with transplants. The impact of COVID-19 has further highlighted the vulnerabilities of dialysis patients, with higher incidence and mortality rates observed, prompting a need for early preventive measures. The market is characterized by a fragmented and competitive landscape, with key players like Fresenius Medical Care, Baxter International Inc., and B. Braun Melsungen AG actively engaging in collaborations and strategic partnerships to maintain their market positions.

The hemodialysis segment is particularly poised for growth due to the increasing incidence of hypertension and diabetes, which lead to kidney failure, and the rising number of patients requiring dialysis. The geriatric population, especially those aged 65 and older, is contributing significantly to the demand for hemodialysis, supported by technological innovations and government initiatives. The introduction of compact-sized machines for home-based treatments and advancements in dialysis technology are further boosting the market. Despite challenges such as complications in dialysis treatment and reimbursement policy issues in developing countries, the overall market outlook remains positive, with ongoing research and development efforts expected to drive future growth.

Explore More

Global Dialysis Concentrate Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Kidney Diseases and Acute Kidney Injury

      2. 1.2.2 Increasing Investment in Research and Development

    3. 1.3 Market Restraints

      1. 1.3.1 Growing Concerns Regarding Reimbursement Policy and Treatment Complications

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Type

      1. 2.1.1 Acid Concentrates

      2. 2.1.2 Bicarbonate Concentrates

      3. 2.1.3 Peritoneal Dialysis Fluid

    2. 2.2 By Application

      1. 2.2.1 Hemodialysis

      2. 2.2.2 Peritoneal Dialysis

    3. 2.3 By Dialysis Site

      1. 2.3.1 Hospital

      2. 2.3.2 Clinics & Dialysis Centers

      3. 2.3.3 Home Dialysis

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle-East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle-East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global Dialysis Concentrate Market Size FAQs

The Global Dialysis Concentrate Market is projected to register a CAGR of 5.73% during the forecast period (2024-2029)

Fresenius Medical Care, Baxter International Inc., B. Braun Melsungen AG, Rockwell Medical and Nipro Renal Solutions are the major companies operating in the Global Dialysis Concentrate Market.

Dialysis Concentrate Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)